BeStock  
Stocks › Biotechnology › AUPH

Aurinia Pharmaceuticals AUPH

US equityMarket cap rank #2690Biotechnology
$14.70 −$0.19 (-1.28%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $14.64 -0.41%
Open$14.69
Prev close$14.89
Day range$14.63 – $14.97
Volume1.34M
Market cap$1.97B
P/E (TTM)6.4
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership67.1%-0.46 pts vs. prior quarter
Institutions holding341-2 vs. prior quarter
Insider trades (recent)27 buys / 23 sellsNet buying
Short interest5.33% of floatDays to cover 10.3 · as of 30 Oct 2026
Short-sale volume share16.4%5-day average of daily volume

Short-sale volume as % of daily volume

6%13%20%27%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$304.9K (8 inflow days, 12 outflow days).

Net flow by order size, last 20 sessions

+$1.3MSuper−$1.6MBig−$1.3MMid−$2.3MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 26.5% of shares outstanding.

Largest holders

  • Tang Capital Management, LLC9.73%
  • BlackRock6.41%
  • ILJIN SNT Co., Ltd3.72%
  • Goldman Sachs Asset Management, L.P.3.65%
  • New Enterprise Associates, Inc.2.96%
  • Two Sigma Investments, LP2.59%
  • Arrowstreet Capital, Limited Partnership2.44%
  • State Street Global Advisors1.93%

By investor type

  • Mutual Fund44.56%
  • Hedge Fund8.99%
  • VC/PE Fund6.68%
  • Public Company4.38%
  • Individual/Insider2.17%
  • Government Pension Fund0.79%
  • Private Company0.73%
  • Insurance Company0.58%

Reported short interest has fallen from 7.23% to 5.33% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
LSV Asset Management Mutual Fund 2026/Q3 +728,265 1.3%
BlackRock Mutual Fund 2026/Q3 +392,293 6.4%
Federated Hermes, Inc. Mutual Fund 2026/Q3 +391,063 0.4%
FMR Mutual Fund 2026/Q3 +147,632 0.4%
Deka Investment GmbH Mutual Fund 2026/Q3 +147,545 0.1%
Principal Global Investors, LLC Mutual Fund 2026/Q3 +118,355 0.2%
Homestead Advisers Corp. Mutual Fund 2026/Q3 +98,400 0.1%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +392,927 0.6%
Goldman Sachs Asset Management, L.P. Mutual Fund 2026/Q3 +4,096,904 3.7%
Allianz Asset Management AG Mutual Fund 2026/Q3 +841,731 0.6%
Tang Capital Management, LLC Mutual Fund 2026/Q3 +814,606 9.7%
BlackRock Mutual Fund 2026/Q3 +347,564 6.2%
Hillsdale Investment Management Inc. Mutual Fund 2026/Q3 +341,000 0.4%
Jupiter Fund Management Plc Mutual Fund 2026/Q3 +291,056 0.8%
ExodusPoint Capital Management, LP Hedge Fund 2026/Q3 +221,620 0.2%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
9 Sep 2026 Stephen Robertson Chief Legal Officer, Corporate Secretary & Chief Compliance Officer Open Market Disposition -11,939 $15.95 408,564
20 Aug 2026 Stephen Robertson Chief Legal Officer, Corporate Secretary & Chief Compliance Officer Open Market Disposition -20,975 $16.97 420,503
4 Jun 2026 Gregory Keenan Former Chief Medical Officer Intent to Sell (Form 144) -9,593 $16.52 –
3 Jun 2026 Tina Nova Independent Director Other Derivative Acquisition +23,931 $15.67 23,931
3 Jun 2026 Craig Johnson Lead Independent Director Other Derivative Acquisition +23,931 $15.67 23,931
3 Jun 2026 Jeffrey Bailey Independent Director Other Derivative Acquisition +23,931 $15.67 23,931
3 Jun 2026 Gregory Keenan Former Chief Medical Officer Intent to Sell (Form 144) -25,000 $16.34 –
3 Jun 2026 Kathleen Goetz Other Derivative Acquisition +23,931 $15.67 23,931
1 Jun 2026 Tang Capital Management, LLC Other Derivative Acquisition +10,000 $15.00 10,000
1 Jun 2026 Gregory Keenan Former Chief Medical Officer Intent to Sell (Form 144) -25,000 $2,164.00 –
1 Jun 2026 Tang Capital Management, LLC Open Market Acquisition +814,606 $15.35 13,044,106
17 May 2026 Michael Hearne Chief Financial Officer Other Acquisition +116,144 – 116,144
17 May 2026 Michael Hearne Chief Financial Officer Other Derivative Acquisition +70,230 $15.28 70,230
17 May 2026 Ryan Cole Chief Operating Officer Other Acquisition +116,144 – 116,144
17 May 2026 Ryan Cole Chief Operating Officer Other Derivative Acquisition +70,230 $15.28 70,230
17 May 2026 Stephen Robertson Chief Legal Officer, Corporate Secretary & Chief Compliance Officer Other Acquisition +115,541 – 180,284
10 May 2026 Peter Greenleaf Consultant Intent to Sell (Form 144) -3,136,201 $15.84 –
10 May 2026 Joseph Miller Former Chief Financial Officer Intent to Sell (Form 144) -500,503 $15.84 –
5 Mar 2026 Gregory Keenan Former Chief Medical Officer Sale to Issuer -8,069 $14.32 154,449
2 Mar 2026 Tang Capital Management, LLC Open Market Acquisition +898,400 $14.33 12,229,500

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 7,137,632 5.3% 10.3
15 Oct 2026 7,780,313 5.8% 9.0
30 Sep 2026 7,920,606 6.0% 9.4
15 Sep 2026 8,576,505 6.4% 11.1
31 Aug 2026 8,978,748 6.7% 8.6
14 Aug 2026 9,615,436 7.2% 8.0

Discussion

No comments yet — be the first to weigh in on AUPH.

Sign in to join the discussion.

Scroll to Top